These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8804003)

  • 21. How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium.
    Rachoin JS; Weisberg LS
    Semin Dial; 2008; 21(3):223-5. PubMed ID: 18363596
    [No Abstract]   [Full Text] [Related]  

  • 22. The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.
    Van Biesen W; Vanholder R; Schepers E; Glorieux G; Dhondt A; Eloot S
    Contrib Nephrol; 2017; 191():168-177. PubMed ID: 28910800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Locatelli F
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051
    [No Abstract]   [Full Text] [Related]  

  • 24. Dialysate biocompatibility: evaluation and expectations.
    Berland Y; Brunet P; Ragon A; Frenkian G; Crevat A
    Contrib Nephrol; 1993; 103():76-88. PubMed ID: 8354065
    [No Abstract]   [Full Text] [Related]  

  • 25. Standardization of water purification in the central dialysis fluid delivery system: validation and parametric method.
    Tomo T; Shinoda T
    Blood Purif; 2009; 27 Suppl 1():36-40. PubMed ID: 19556762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Friedman EA
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049
    [No Abstract]   [Full Text] [Related]  

  • 27. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
    Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
    Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodiafiltration with on-line production of bicarbonate infusate. A new standard for high-efficiency, low-cost dialysis in elderly and uncompliant patients.
    Canaud B; NGuyen QV; Polito C; Stec F; Mion C
    Contrib Nephrol; 1989; 74():91-100. PubMed ID: 2702151
    [No Abstract]   [Full Text] [Related]  

  • 30. The new standard of fluids for hemodialysis in Japan.
    Kawanishi H; Masakane I; Tomo T
    Blood Purif; 2009; 27 Suppl 1():5-10. PubMed ID: 19556756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of pyrogens during clinical hemodialysis.
    Weingast JA; VanDeKerkhove KM; Eiger SM; Kluger MJ; Port FK
    Trans Am Soc Artif Intern Organs; 1985; 31():359-62. PubMed ID: 3837472
    [No Abstract]   [Full Text] [Related]  

  • 32. [Physicochemical and bacteriological study of water in the Federal Capital and greater Buenos Aires in relation to its use in hemodialysis].
    López Blanco OA; Manes de Gazzolo B; Silva ML; Gotlieb D
    Medicina (B Aires); 1979; 39(1):58-64. PubMed ID: 530083
    [No Abstract]   [Full Text] [Related]  

  • 33. Worldwide guidelines for the preparation and quality management of dialysis fluid and their implementation.
    Ward RA
    Blood Purif; 2009; 27 Suppl 1():2-4. PubMed ID: 19556755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G; Beck GJ; Cheung AK; Daugirdas JT; Greene T; Kusek JW; Allon M; Bailey J; Delmez JA; Depner TA; Dwyer JT; Levey AS; Levin NW; Milford E; Ornt DB; Rocco MV; Schulman G; Schwab SJ; Teehan BP; Toto R;
    N Engl J Med; 2002 Dec; 347(25):2010-9. PubMed ID: 12490682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Success and challenge in dialysis therapy.
    Himmelfarb J
    N Engl J Med; 2002 Dec; 347(25):2068-70. PubMed ID: 12490690
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical effect of purification of dialysis fluids, evidence and experience.
    Schindler R
    Blood Purif; 2009; 27 Suppl 1():20-2. PubMed ID: 19556759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodialysis-associated febrile episodes: surveillance before and after major alteration in the water treatment system.
    Gaynes R; Friedman C; Maclaren C; Foley K; Swartz R
    Int J Artif Organs; 1990 Aug; 13(8):482-7. PubMed ID: 2228291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis.
    Schindler R; Lonnemann G; Schäffer J; Shaldon S; Koch KM; Krautzig S
    Nephron; 1994; 68(2):229-33. PubMed ID: 7830861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.
    Clark WR; Hamburger RJ; Lysaght MJ
    Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysate composition and function: the effects of water content.
    Hull AR
    Med Instrum; 1974; 8(3):195-6. PubMed ID: 4838447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.